ROSS GEORGE K

CIK 00010687241 companyPALATINE, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001068724

Recent Transactions

50 trades

Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2026-01-02−50,000→ 50,000 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2026-01-02−50,000→ 0 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2026-01-02+50,000→ 595,903 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2025-01-02−50,000→ 50,000 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2025-01-02−50,000→ 0 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2025-01-02+50,000→ 545,503 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2024-01-02+50,000→ 495,503 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2024-01-02−50,000→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2024-01-02−50,000→ 50,000 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2023-01-03+66,666→ 445,503 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2023-01-03−50,000→ 50,000 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2023-01-03−66,666→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2022-01-03−66,666→ 66,666 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2022-01-03+66,666→ 378,837 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2022-01-03−66,666→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2021 Plan)
2021-05-25+66,666→ 66,666 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2021-01-04−54,790→ 0 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2021-01-04+54,790→ 312,171 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2020-01-02+50,000→ 261,005 total
Tax Payment
ACURA PHARMACEUTICALS, INC
Common Stock
2020-01-02$0.23/sh−3,624→ 257,381 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2020-01-02+54,790→ 54,790 total
Disposition to Issuer
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2020-01-02$0.23/sh−33,333→ 0 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2020-01-02+50,000→ 33,333 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2019-01-02+66,666→ 211,005 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2019-01-02−66,666→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2019-01-02+83,333→ 83,333 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2018-01-02+82,774→ 144,339 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2014 Plan)
2018-01-02−82,774→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units (2017 Plan)
2018-01-02+66,666→ 66,666 total
Purchase
ACURA PHARMACEUTICALS, INC
Common Stock
2017-12-14$0.10/sh+50,000→ 61,565 total
Disposition to Issuer
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2017-01-03$0.77/sh−490→ 735 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2017-01-03+735→ 11,565 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2017-01-03−735→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2017-01-03+59,523→ 59,523 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2016-01-04+8,074→ 10,830 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2016-01-04−8,074→ 2,450 total
Disposition to Issuer
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2016-01-04$2.50/sh−3,460→ 10,524 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2016-01-04+22,026→ 24,476 total
Award
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2015-01-02+51,546→ 51,546 total
Disposition to Issuer
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2015-01-02$0.45/sh−7,352→ 18,382 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Common Stock
2015-01-02+11,030→ 14,030 total
Tax Payment
ACURA PHARMACEUTICALS, INC
Common Stock
2015-01-02$0.45/sh−246→ 13,784 total
Exercise/Conversion
ACURA PHARMACEUTICALS, INC
Restricted Stock Units
2015-01-02−11,030→ 25,734 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2013-01-02+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2012-01-03+15,000→ 15,000 total
Purchase
ACURA PHARMACEUTICALS, INC
Common Stock
2011-08-23$3.04/sh+3,000→ 3,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2011-01-03+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2010-01-04+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2009-01-02+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2008-01-24+15,000→ 15,000 total

Companies

ACURA PHARMACEUTICALS, INC
Director

Recent Filings

Address

ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT, SUITE 120

PALATINE, IL, 60067

View on SEC.gov